HK1049996A1 - 6-FluorobicycloÄ3.1.0Ühexane derivatives - Google Patents
6-FluorobicycloÄ3.1.0Ühexane derivativesInfo
- Publication number
- HK1049996A1 HK1049996A1 HK03102289A HK03102289A HK1049996A1 HK 1049996 A1 HK1049996 A1 HK 1049996A1 HK 03102289 A HK03102289 A HK 03102289A HK 03102289 A HK03102289 A HK 03102289A HK 1049996 A1 HK1049996 A1 HK 1049996A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- group
- cycloalkyl
- hydrogen atom
- alkoxy group
- atom
- Prior art date
Links
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000012661 Dyskinesia Diseases 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 abstract 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 abstract 1
- 206010028570 Myelopathy Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000006843 cycloalkyl-C1-5-alkyl Chemical group 0.000 abstract 1
- 125000005366 cycloalkylthio group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 239000003823 glutamate receptor agonist Substances 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Filling Or Discharging Of Gas Storage Vessels (AREA)
- Fertilizers (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24634398 | 1998-08-31 | ||
JP8260799 | 1999-03-25 | ||
PCT/JP1999/003984 WO2000012464A1 (fr) | 1998-08-31 | 1999-07-26 | Derives de 6-fluorobicyclo[3. 1.0]hexane |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1049996A1 true HK1049996A1 (en) | 2003-06-06 |
Family
ID=26423636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03102289A HK1049996A1 (en) | 1998-08-31 | 2003-03-31 | 6-FluorobicycloÄ3.1.0Ühexane derivatives |
Country Status (13)
Country | Link |
---|---|
US (1) | US6333428B1 (fr) |
EP (1) | EP1110943B1 (fr) |
KR (1) | KR100469182B1 (fr) |
CN (1) | CN1247527C (fr) |
AT (1) | ATE269293T1 (fr) |
AU (1) | AU746806B2 (fr) |
CA (1) | CA2341865C (fr) |
DE (1) | DE69918136T2 (fr) |
DK (1) | DK1110943T3 (fr) |
ES (1) | ES2222715T3 (fr) |
HK (1) | HK1049996A1 (fr) |
PT (1) | PT1110943E (fr) |
WO (1) | WO2000012464A1 (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6313159B1 (en) | 1999-08-20 | 2001-11-06 | Guilford Pharmaceuticals Inc. | Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors |
KR100699393B1 (ko) * | 2000-06-28 | 2007-03-26 | 다이쇼 세이야꾸 가부시끼가이샤 | 중간체 및 이를 사용한 불소 함유 카르복실산 유도체의제조 방법 |
EP1295865A4 (fr) * | 2000-06-28 | 2005-06-01 | Taisho Pharmaceutical Co Ltd | Nouveaux derives d'acide dicarboxylique |
WO2003006489A2 (fr) * | 2001-07-09 | 2003-01-23 | Eli Lilly And Company | Promedicaments d'acides amines excitateurs |
WO2003045898A1 (fr) * | 2001-11-23 | 2003-06-05 | Eli Lilly And Company | Promedicaments d'acides amines excitateurs |
WO2003057661A1 (fr) * | 2001-12-21 | 2003-07-17 | Eli Lilly And Company | Promedicaments a base d'acides amines excitateurs |
MXPA04006322A (es) * | 2001-12-27 | 2004-10-04 | Taisho Pharmaceutical Co Ltd | Derivados de 6-fluorobiciclo[3.1.0]hexano. |
KR20080058509A (ko) * | 2002-06-11 | 2008-06-25 | 일라이 릴리 앤드 캄파니 | 흥분성 아미노산의 전구약물 |
WO2004004706A1 (fr) * | 2002-07-05 | 2004-01-15 | Eli Lilly And Company | Promedicaments a base d'acides amines excitateurs |
NZ544131A (en) | 2003-06-26 | 2009-11-27 | Taisho Pharmaceutical Co Ltd | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
US7786314B2 (en) * | 2003-11-07 | 2010-08-31 | Taisho Pharmaceutical Co., Ltd | Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto |
US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
CA2620333A1 (fr) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenese par modulation du recepteur muscarinique |
EP2258359A3 (fr) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline |
EP2377530A3 (fr) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation de neurogénèse par inhibition PDE |
WO2007053596A1 (fr) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Modulation de la neurogenese dont la mediation est assuree par recepteur gaba |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
EP2026813A2 (fr) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | Neurogenèse induite par le récepteur 5ht |
KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
US8252937B2 (en) | 2007-09-14 | 2012-08-28 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones |
AU2008297877C1 (en) * | 2007-09-14 | 2013-11-07 | Addex Pharma S.A. | 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones |
BRPI0816767B8 (pt) | 2007-09-14 | 2021-05-25 | Addex Pharmaceuticals Sa | composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos |
US8785486B2 (en) * | 2007-11-14 | 2014-07-22 | Janssen Pharmaceuticals, Inc. | Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
EP2679570A3 (fr) * | 2008-05-21 | 2014-07-02 | Taisho Pharmaceutical Co., Ltd. | Procédé de production de dérivé de bicyclo[3.1.0]hexane |
ES2439291T3 (es) | 2008-09-02 | 2014-01-22 | Janssen Pharmaceuticals, Inc. | Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos |
EP2346505B1 (fr) | 2008-10-16 | 2014-04-23 | Janssen Pharmaceuticals, Inc. | DÉRIVÉS D'INDOLE ET DE BENZOMORPHOLINE EN TANT QUE MODULATEURS DE RÉCEPTEURS MÉTABOTROPIQUEs DU GLUTAMATE |
WO2010060589A1 (fr) | 2008-11-28 | 2010-06-03 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Dérivés d'indole et de benzoxazine comme modulateurs des récepteurs métabotropiques au glutamate |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
WO2010111080A2 (fr) | 2009-03-27 | 2010-09-30 | Eli Lilly And Company | Traitement optimisé de la schizophrénie |
NZ596053A (en) | 2009-05-12 | 2013-05-31 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
CN102439008B (zh) | 2009-05-12 | 2015-04-29 | 杨森制药有限公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途 |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
ES2536433T3 (es) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
WO2012173850A1 (fr) | 2011-06-17 | 2012-12-20 | Eli Lilly And Company | Dérivés d'acide bicyclo(3.1.0)hexane-2,6-dicarboxylique en tant qu'agoniste du récepteur mglu2 |
AR089718A1 (es) * | 2012-02-01 | 2014-09-10 | Lilly Co Eli | AGONISTAS DE mGlu2/3 |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
DK3096790T3 (da) | 2014-01-21 | 2019-10-07 | Janssen Pharmaceutica Nv | Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse |
DK3431106T3 (da) | 2014-01-21 | 2021-03-15 | Janssen Pharmaceutica Nv | Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750566A (en) | 1994-08-12 | 1998-05-12 | Eli Lilly And Company | Synthetic excitatory amino acids |
PL182285B1 (pl) | 1994-08-12 | 2001-12-31 | Lilly Co Eli | Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL |
IL118727A (en) * | 1995-06-29 | 2003-01-12 | Lilly Co Eli | (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid |
ZA969485B (en) | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
EA000894B1 (ru) | 1995-11-16 | 2000-06-26 | Эли Лилли Энд Компани | Замещенные бициклогексанкарбоновые кислоты и их производные в качестве антагонистов рецептора возбуждающих аминокислот, способ их получения и применение |
GB9605429D0 (en) | 1995-11-16 | 1996-05-15 | Lilly Co Eli | Excitatory amino acid receptor antagonists |
US5912248A (en) * | 1995-11-16 | 1999-06-15 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
JP3727791B2 (ja) | 1998-01-08 | 2005-12-14 | ファイザー・プロダクツ・インク | 二環式[3.1.0]ヘキサン及び関連化合物 |
JP4171549B2 (ja) | 1998-01-28 | 2008-10-22 | 大正製薬株式会社 | 含フッ素アミノ酸誘導体 |
AU734812B2 (en) | 1998-01-28 | 2001-06-21 | Taisho Pharmaceutical Co., Ltd. | Fluorine-containing amino acid derivatives |
-
1999
- 1999-07-26 US US09/763,408 patent/US6333428B1/en not_active Expired - Lifetime
- 1999-07-26 AT AT99931532T patent/ATE269293T1/de active
- 1999-07-26 AU AU48007/99A patent/AU746806B2/en not_active Ceased
- 1999-07-26 EP EP99931532A patent/EP1110943B1/fr not_active Expired - Lifetime
- 1999-07-26 DE DE69918136T patent/DE69918136T2/de not_active Expired - Lifetime
- 1999-07-26 WO PCT/JP1999/003984 patent/WO2000012464A1/fr active IP Right Grant
- 1999-07-26 CN CNB998101834A patent/CN1247527C/zh not_active Expired - Fee Related
- 1999-07-26 PT PT99931532T patent/PT1110943E/pt unknown
- 1999-07-26 ES ES99931532T patent/ES2222715T3/es not_active Expired - Lifetime
- 1999-07-26 CA CA002341865A patent/CA2341865C/fr not_active Expired - Fee Related
- 1999-07-26 KR KR10-2001-7002530A patent/KR100469182B1/ko not_active IP Right Cessation
- 1999-07-26 DK DK99931532T patent/DK1110943T3/da active
-
2003
- 2003-03-31 HK HK03102289A patent/HK1049996A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE69918136D1 (de) | 2004-07-22 |
AU4800799A (en) | 2000-03-21 |
EP1110943A1 (fr) | 2001-06-27 |
ATE269293T1 (de) | 2004-07-15 |
PT1110943E (pt) | 2004-08-31 |
DK1110943T3 (da) | 2004-10-11 |
WO2000012464A1 (fr) | 2000-03-09 |
US6333428B1 (en) | 2001-12-25 |
KR20010092268A (ko) | 2001-10-24 |
CN1247527C (zh) | 2006-03-29 |
EP1110943A4 (fr) | 2002-07-10 |
AU746806B2 (en) | 2002-05-02 |
CA2341865C (fr) | 2006-01-17 |
CA2341865A1 (fr) | 2000-03-09 |
KR100469182B1 (ko) | 2005-02-02 |
ES2222715T3 (es) | 2005-02-01 |
DE69918136T2 (de) | 2005-07-07 |
EP1110943B1 (fr) | 2004-06-16 |
CN1383423A (zh) | 2002-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1049996A1 (en) | 6-FluorobicycloÄ3.1.0Ühexane derivatives | |
HK1036792A1 (en) | Fluorine-containing amino acid derivatives. | |
WO2003051315A3 (fr) | Modulateurs triazole substitues par heteroaryle du recepteur metabotropique 5 du glutamate | |
TW200634016A (en) | Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors | |
SG155938A1 (en) | Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors | |
WO2004089303A3 (fr) | Modulateurs au pyrazole a substitution diaryle du recepteur-5 de glutamate metabotropique | |
NZ590951A (en) | Cyclic nucleotide phosphodiesterases PDE10 inhibitors for treating neurological disorders | |
WO2004089306A3 (fr) | Modulateurs au triazole a substitution diaryle du recepteur-5 de glutamate metabotropique | |
BG106228A (en) | Substituted imidazothiazoles as antidepressant agents | |
EP1099692A4 (fr) | Derives d'amine cyclique n,n-substitues | |
AU7618191A (en) | 3-(1-thiazolidinylbutyl-4-piperazinyl)-1H-indazoles, a process for their preparation and their use as medicaments | |
AU1154092A (en) | Cyclic compound | |
EP1153922A4 (fr) | Derives d'heterodiazinone | |
HUT58339A (en) | Process for producing new organosilane derivatives and pharmaceutical compositions containing them | |
AU696458B2 (en) | Optically active, substituted phenylalkylamine derivatives | |
EP0473993A3 (en) | Novel peptide derivatives and their pharmaceutical use |